Follow the people · Insider
Richard Alistair Stewart
Richard Alistair Stewart files insider transactions with the SEC as a chief executive officer of Achieve Life Sciences (ACHV). We hold 1 disclosed purchase or sale filed since 3 August 2017, 1 of them in the last 90 days.
- Files forACHV
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure21 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 August 2017 — 19 August 2026Chief Executive Officer · Achieve Life Sciences (ACHV)48 Form 4 lines · source: SEC Form 4
Everything they disclosed
48 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 20,626 shares of Achieve Life SciencesSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- was granted 25,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 429 July 2026Stock Option (right to buy) · traded 27 July 2026 · filed 29 July 2026
- was granted 16,700 shares of Achieve Life Sciences (a derivative holding)SEC Form 429 July 2026Restricted Stock Unit (RSU) · traded 27 July 2026 · filed 29 July 2026
- was granted 645,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 430 January 2026Stock Option (right to buy) · traded 28 January 2026 · filed 30 January 2026
- was granted 645,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 430 January 2026Stock Option (right to buy) · traded 28 January 2026 · filed 30 January 2026
- exercised options over 140,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 422 September 2025Performance Restricted Stock Unit (PRSU) · traded 18 September 2025 · filed 22 September 2025
- exercised options over 157,500 shares of Achieve Life Sciences (a derivative holding)SEC Form 422 September 2025Performance Restricted Stock Unit (PRSU) · traded 18 September 2025 · filed 22 September 2025
- exercised options over 297,500 shares of Achieve Life SciencesSEC Form 422 September 2025Common Stock · traded 18 September 2025 · filed 22 September 2025
- ▼ sold on the open market 129,501 shares of Achieve Life SciencesSEC Form 422 September 2025Common Stock · traded 18 September 2025 · filed 22 September 2025
- was granted 140,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 48 September 2025Performance Restricted Stock Unit · traded 4 September 2025 · filed 8 September 2025
- was granted 157,500 shares of Achieve Life Sciences (a derivative holding)SEC Form 48 September 2025Performance Restricted Stock Unit · traded 4 September 2025 · filed 8 September 2025
- ▲ bought on the open market 10,000 shares of Achieve Life SciencesSEC Form 419 March 2025Common Stock · traded 17 March 2025 · filed 19 March 2025
- was granted 157,500 shares of Achieve Life Sciences (a derivative holding)SEC Form 414 January 2025Performance Restricted Stock Unit (PRSU) · traded 13 January 2025 · filed 14 January 2025
- was granted 67,500 shares of Achieve Life Sciences (a derivative holding)SEC Form 414 January 2025Stock Option (right to buy) · traded 13 January 2025 · filed 14 January 2025
- exercised options over 22,500 shares of Achieve Life Sciences (a derivative holding)SEC Form 423 April 2024Performance Restricted Stock Unit (PRSU) · traded 19 April 2024 · filed 23 April 2024
- exercised options over 22,500 shares of Achieve Life SciencesSEC Form 423 April 2024Common Stock · traded 19 April 2024 · filed 23 April 2024
- had shares withheld for tax on 10,125 shares of Achieve Life SciencesSEC Form 423 April 2024Common Stock · traded 19 April 2024 · filed 23 April 2024
- ▲ bought on the open market 10,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 46 March 2024Common Stock Warrants (right to buy) · traded 4 March 2024 · filed 6 March 2024
- ▲ bought on the open market 10,000 shares of Achieve Life SciencesSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- was granted 140,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 424 January 2024Performance Restricted Stock Unit (PRSU) · traded 22 January 2024 · filed 24 January 2024
- was granted 60,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 424 January 2024Stock Option (right to buy) · traded 22 January 2024 · filed 24 January 2024
- exercised options over 5,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 41 May 2023Performance Restricted Stock Unit (PRSU) · traded 28 April 2023 · filed 1 May 2023
- exercised options over 5,000 shares of Achieve Life SciencesSEC Form 41 May 2023Common Stock · traded 28 April 2023 · filed 1 May 2023
- had shares withheld for tax on 2,250 shares of Achieve Life SciencesSEC Form 41 May 2023Common Stock · traded 28 April 2023 · filed 1 May 2023
- exercised options over 22,500 shares of Achieve Life Sciences (a derivative holding)SEC Form 424 April 2023Performance Restricted Stock Unit (PRSU) · traded 21 April 2023 · filed 24 April 2023
- exercised options over 22,500 shares of Achieve Life SciencesSEC Form 424 April 2023Common Stock · traded 21 April 2023 · filed 24 April 2023
- had shares withheld for tax on 10,125 shares of Achieve Life SciencesSEC Form 424 April 2023Common Stock · traded 21 April 2023 · filed 24 April 2023
- was granted 75,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 427 January 2023Performance Restricted Stock Unit (PRSU) · traded 25 January 2023 · filed 27 January 2023
- was granted 75,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 427 January 2023Stock Option (right to buy) · traded 25 January 2023 · filed 27 January 2023
- exercised options over 5,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 429 April 2022Performance Restricted Stock Unit (PRSU) · traded 28 April 2022 · filed 29 April 2022
- exercised options over 5,000 shares of Achieve Life SciencesSEC Form 429 April 2022Common Stock · traded 28 April 2022 · filed 29 April 2022
- had shares withheld for tax on 2,250 shares of Achieve Life SciencesSEC Form 429 April 2022Common Stock · traded 28 April 2022 · filed 29 April 2022
- was granted 45,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 45 January 2022Performance Restricted Stock Unit (PRSU) · traded 3 January 2022 · filed 5 January 2022
- was granted 45,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 45 January 2022Stock Option (right to buy) · traded 3 January 2022 · filed 5 January 2022
- was granted 10,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 428 January 2021Performance Restricted Stock Unit (PRSU) · traded 26 January 2021 · filed 28 January 2021
- was granted 50,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 428 January 2021Stock Option (right to buy) · traded 26 January 2021 · filed 28 January 2021
- was granted 15,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 418 November 2020Stock Option (right to buy) · traded 16 November 2020 · filed 18 November 2020
- was granted 450,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 430 January 2020Stock Option (right to buy) · traded 28 January 2020 · filed 30 January 2020
- ▲ bought on the open market 17,500 shares of Achieve Life SciencesSEC Form 428 May 2019Common Stock · traded 23 May 2019 · filed 28 May 2019
- was granted 75,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 431 January 2019Stock Option (right to buy) · traded 29 January 2019 · filed 31 January 2019
- was granted 25,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 431 January 2019Stock Option (right to buy) · traded 29 January 2019 · filed 31 January 2019
- was granted 101,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 421 September 2018Stock Option (right to buy) · traded 20 September 2018 · filed 21 September 2018
- was granted 52,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 430 July 2018Stock Option (right to buy) · traded 26 July 2018 · filed 30 July 2018
- was granted 1,950,309 shares of Achieve Life SciencesSEC Form 411 August 2017Common Stock · traded 1 August 2017 · filed 11 August 2017
- was granted 71,861 shares of Achieve Life SciencesSEC Form 411 August 2017Common Stock · traded 1 August 2017 · filed 11 August 2017
- was granted 176,418 shares of Achieve Life SciencesSEC Form 411 August 2017Common Stock · traded 1 August 2017 · filed 11 August 2017
- was granted 22,487,319 shares of Achieve Life SciencesSEC Form 43 August 2017Common Stock · traded 1 August 2017 · filed 3 August 2017
- was granted 848,578 shares of Achieve Life SciencesSEC Form 43 August 2017Common Stock · traded 1 August 2017 · filed 3 August 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.